Novel peptide inhibitors of angiotensin-converting enzyme 2
Novel peptide inhibitors of angiotensin-converting enzyme 2
复制标题
DOI:
10.1074/jbc.m212934200
复制
发表时间:
2003-05-02
影响因子:
4.8
通讯作者:
Ladner, RC
中科院分区:
文献类型:
--
作者:
Huang, LL;Sexton, DJ;Ladner, RC
Angiotensin-converting enzyme 2 (ACE2), a recently identified human homolog of ACE, is a novel metallocarboxypeptidase with specificity, tissue distribution, and function distinct from those of ACE. ACE2 may play a unique role in the renin-angiotensin system and mediate cardiovascular and renal function. Here we report the discovery of ACE2 peptide inhibitors through selection of constrained peptide libraries displayed on phage. Six constrained peptide libraries were constructed and selected against FLAG-tagged ACE2 target. ACE2 peptide binders were identified and classified into five groups, based on their effects on ACE2 activity. Peptides from the first three classes exhibited none, weak, or mode-rate inhibition on ACE2. Peptides from the fourth class exhibited strong inhibition, with equilibrium inhibition constants (K-i values) from 0.38 to 1.7 gm. Peptides from the fifth class exhibited very strong inhibition, with K-i values